Literature DB >> 19562264

[Large vessel vasculitis].

L Caspary1, S Schellong.   

Abstract

Large vessel vasculitis is characterized by local inflammation of the vessel wall of the aorta and its first and second degree branches. Giant cells are found regularly. The process leads to stenoses and occlusions as well as to aneurysmatic dilatation. Recent progress in vascular imaging (colour Doppler ultrasound, MRI and PET) allows to detect Takayasu arteritis at an earlier stage and to reveal the involvement of larger arteries in temporal arteritis (giant cell arteritis, GCA). With increasing frequency, a subtype of predominantly female and less aged GCA patients without cranial symptoms is noticed in whom obstructions are prevailing in the proximal arm vessels or in the aorta. The latter may be affected exclusively. Initial therapy is based on corticosteroids. In GCA, methotrexate hitherto is the only other immunosuppressive drug that has proved to be helpful. Disease activity has to be controlled both by laboratory parameters and vascular imaging.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562264     DOI: 10.1007/s00108-009-2363-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

Review 1.  Medium- and large-vessel vasculitis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  N Engl J Med       Date:  2003-07-10       Impact factor: 91.245

2.  Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey.

Authors:  Bhaskar Dasgupta; Carlo Salvarani; Michael Schirmer; Cynthia S Crowson; Hilal Maradit-Kremers; Andrew Hutchings; Eric L Matteson
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666

3.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

4.  Diagnosis of early Takayasu arteritis with sonography.

Authors:  W A Schmidt; A Nerenheim; E Seipelt; C Poehls; E Gromnica-Ihle
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

5.  Surgical treatment of ascending aortic aneurysms in patients with giant cell aortitis.

Authors:  Kenton J Zehr; Alok Mathur; Thomas A Orszulak; Charles J Mullany; Hartzell V Schaff
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

6.  A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.

Authors:  G Myklebust; J T Gran
Journal:  Br J Rheumatol       Date:  1996-11

7.  Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Authors:  Gary S Hoffman; Maria C Cid; Karen E Rendt-Zagar; Peter A Merkel; Cornelia M Weyand; John H Stone; Carlo Salvarani; Weichun Xu; Sudha Visvanathan; Mahboob U Rahman
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

8.  Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.

Authors:  E S Molloy; C A Langford; T M Clark; C E Gota; G S Hoffman
Journal:  Ann Rheum Dis       Date:  2008-08-03       Impact factor: 19.103

9.  Vessel-specific Toll-like receptor profiles in human medium and large arteries.

Authors:  Olga Pryshchep; Wei Ma-Krupa; Brian R Younge; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  3 in total

Review 1.  [Ultrasound investigation of vessels supplying the extremities].

Authors:  S M Schellong
Journal:  Radiologe       Date:  2009-11       Impact factor: 0.635

2.  [Bitemporal scalp necrosis : a very rare manifestation of giant cell arteritis].

Authors:  E M Valesky; M Wahle; S Vranes; M Wolter; R Kaufmann; M Meissner
Journal:  Z Rheumatol       Date:  2012-11       Impact factor: 1.372

Review 3.  Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.

Authors:  Xiaolong Qi; Jiahong Xu; Fei Wang; Junjie Xiao
Journal:  Oxid Med Cell Longev       Date:  2012-11-28       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.